Replies to post #442192 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Always the risk of things falling through.

We’re of the same mind on this - there are of course other possibilities, but visually a buyout makes the most sense. A joint venture, licensing or other types of collaborations means the company has to be properly managed, staffed and governed, and there’s nothing noteworthy on that front.

Could everything be behind the scenes? Maybe, but some things would already be disclosed and could not be kept invisible.

[CrashOverride]

Merck bought Acceleron before sotatercept had FDA approval. That drug treats a niche form of hypertension with a smaller patient population than GBM.

So in my opinion the buyout could come at any time.

https://www.biospace.com/article/merck-strikes-with-11-billion-deal-for-acceleron-and-phase-iii-pah-drug/